BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 18459180)

  • 1. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
    Lee DH; Han JY; Kim HT; Yoon SJ; Pyo HR; Cho KH; Shin SH; Yoo H; Lee SH; Lee JS
    Cancer; 2008 Jul; 113(1):143-9. PubMed ID: 18459180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology.
    Moscetti L; Nelli F; Felici A; Rinaldi M; De Santis S; D'Auria G; Mansueto G; Tonini G; Sperduti I; Pollera FC
    Cancer; 2007 Jan; 109(2):274-81. PubMed ID: 17154161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
    Mehta MP; Shapiro WR; Phan SC; Gervais R; Carrie C; Chabot P; Patchell RA; Glantz MJ; Recht L; Langer C; Sur RK; Roa WH; Mahe MA; Fortin A; Nieder C; Meyers CA; Smith JA; Miller RA; Renschler MF
    Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1069-76. PubMed ID: 18977094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment outcome for patients with primary nonsmall-cell lung cancer and synchronous brain metastasis.
    Chidel MA; Suh JH; Greskovich JF; Kupelian PA; Barnett GH
    Radiat Oncol Investig; 1999; 7(5):313-9. PubMed ID: 10580901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
    Yue X; Zang QC
    Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Whole-brain radiotherapy combined with COAPC regimen in patients with non-small cell lung cancer].
    Chen LK; Xu GC; Liu GZ; Liang Y; Liu JL; Zhou XM
    Ai Zheng; 2003 Apr; 22(4):407-10. PubMed ID: 12704000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
    Hu C; Chang EL; Hassenbusch SJ; Allen PK; Woo SY; Mahajan A; Komaki R; Liao Z
    Cancer; 2006 May; 106(9):1998-2004. PubMed ID: 16572401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
    Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
    Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
    Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic chemotherapy after cranial irradiation in patients with brain metastases from non-small cell lung cancer: a retrospective study.
    Kim JH; Kim HS; Kwon JH; Park S; Kim HY; Jung JY; Kim HJ; Song HH; Lee GW; Lee SI; Gong SJ; Lee JA; Kim KJ; Zang DY
    Lung Cancer; 2009 Mar; 63(3):405-9. PubMed ID: 18621432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Whole brain irradiation for non-small-cell lung cancer with brain metastasis].
    Shi AH; Zhu GY; Yu R; Ma HM; Liu CQ; Su X; Sun Y; Cai Y; Xu XN; Zhang SW; Xu B
    Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):545-8. PubMed ID: 18069640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases.
    Mehta MP; Tsao MN; Whelan TJ; Morris DE; Hayman JA; Flickinger JC; Mills M; Rogers CL; Souhami L
    Int J Radiat Oncol Biol Phys; 2005 Sep; 63(1):37-46. PubMed ID: 16111570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiotherapy plus carboplatin and teniposide in patients with brain metastases from non small cell lung cancer.
    Pronzato P; Bruna F; Neri E; Roveri D; Trabucchi A; Vanoli M; Vigani A; Vaira F; Losardo P; Bertelli G
    Anticancer Res; 1995; 15(2):517-9. PubMed ID: 7539236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase III trial comparing bexarotene (L1069-49)/cisplatin/vinorelbine with cisplatin/vinorelbine in chemotherapy-naive patients with advanced or metastatic non-small-cell lung cancer: SPIRIT I.
    Ramlau R; Zatloukal P; Jassem J; Schwarzenberger P; Orlov SV; Gottfried M; Pereira JR; Temperley G; Negro-Vilar R; Rahal S; Zhang JK; Negro-Vilar A; Dziewanowska ZE
    J Clin Oncol; 2008 Apr; 26(11):1886-92. PubMed ID: 18398154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
    Knisely JP; Berkey B; Chakravarti A; Yung AW; Curran WJ; Robins HI; Movsas B; Brachman DG; Henderson RH; Mehta MP
    Int J Radiat Oncol Biol Phys; 2008 May; 71(1):79-86. PubMed ID: 18164847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel/carboplatin chemotherapy as primary treatment of brain metastases in non-small cell lung cancer: a preliminary report.
    Lee JS; Pisters KM; Komaki R; Glisson BS; Khuri FR; Schea R; Fossella FV
    Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-52-S12-55. PubMed ID: 9331122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung.
    Guerrieri M; Wong K; Ryan G; Millward M; Quong G; Ball DL
    Lung Cancer; 2004 Oct; 46(1):107-11. PubMed ID: 15364138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
    Suh JH; Stea B; Nabid A; Kresl JJ; Fortin A; Mercier JP; Senzer N; Chang EL; Boyd AP; Cagnoni PJ; Shaw E
    J Clin Oncol; 2006 Jan; 24(1):106-14. PubMed ID: 16314619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in the natural history of nonsmall cell lung cancer (NSCLC)--comparison of outcomes and characteristics in patients with advanced NSCLC entered in Eastern Cooperative Oncology Group trials before and after 1990.
    Wakelee HA; Bernardo P; Johnson DH; Schiller JH
    Cancer; 2006 May; 106(10):2208-17. PubMed ID: 16604529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
    Mehta MP; Rodrigus P; Terhaard CH; Rao A; Suh J; Roa W; Souhami L; Bezjak A; Leibenhaut M; Komaki R; Schultz C; Timmerman R; Curran W; Smith J; Phan SC; Miller RA; Renschler MF
    J Clin Oncol; 2003 Jul; 21(13):2529-36. PubMed ID: 12829672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.